Variant report
Variant | esv3515594 |
---|---|
Chromosome Location | chr4:142422097-142422680 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:142421998..142424894-chr4:142429511..142431178,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs534158064 | chr4:142422097-142422098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs536600374 | chr4:142422104-142422105 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs186182330 | chr4:142422148-142422149 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs570152564 | chr4:142422170-142422171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs72940682 | chr4:142422185-142422186 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs559194420 | chr4:142422221-142422222 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs563016605 | chr4:142422223-142422224 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs541370979 | chr4:142422245-142422246 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs6838410 | chr4:142422252-142422253 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs574371521 | chr4:142422297-142422298 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs541390188 | chr4:142422301-142422302 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs563077381 | chr4:142422394-142422395 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs191086477 | chr4:142422472-142422473 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs376548772 | chr4:142422482-142422483 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs563928266 | chr4:142422485-142422486 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs202152117 | chr4:142422503-142422504 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs370948085 | chr4:142422512-142422513 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs11397443 | chr4:142422525-142422526 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs183628396 | chr4:142422540-142422541 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs199697533 | chr4:142422545-142422546 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs4956297 | chr4:142422650-142422651 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs568315022 | chr4:142422662-142422663 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 16272173 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Mental retardation | 17901693 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Obesity | 20622171 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Breast cancer | 22048815 | CNVD |
Autism | 22241247 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:142421800-142422200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
2 | chr4:142422200-142423200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr4:142422200-142424400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |